Male Hormones Drive Some Female Breast Cancers
Most breast cancers are fueled by the female hormone estrogen. In an interesting twist, scientists have discovered that a male hormone ignites breast tumor growth in some women.
PSA Tests - Not Just for Prostate Cancer Anymore
The most common form of cancer in women may soon be detected using a test that diagnoses the most common type of cancer in men. The PSA test may soon be used to detect breast cancer.
"Chemo Brain" a Myth?
People undergoing chemotherapy often blame their forgetfulness and mental sluggishness on what's called"chemo brain." New research finds no link in older breast cancer patients.
Your Cancer Family Tree
As with all of medicine these days, researchers are now finding that cancer screenings need to be personalized. Your screening schedules should be based on your family history.
Dual Therapy Helps Treat Aggressive Breast Cancer
Aggressive HER-2 positive metastatic breast cancer is difficult to treat. A recent study shows dual medication therapy offers new treatment options - and hope.
Treating More Than the Breast Cancer
Older women diagnosed with breast cancer often have other health problems which can affect their overall survival. So it's important for primary care physicians to work with oncologists to treat the whole woman.
Evolving Mammogram Strategy
Just like a good bra, one size definitely does not fit all when it comes to considering when to begin mammograms. In another step toward personalized healthcare, a new study suggests standards should be modified regarding when to begin mammograms.
FDA Panel Rules Against Avastin - Again
In an unprecedented appeals hearing, the US Food and Drug Administration (FDA) has not changed its mind. An FDA panel voted that the drug Avastin no longer be approved for treating late-stage breast cancers.
Not Receiving Lifesaving Cancer Treatment
Radiation following mastectomies is not usually recommended, except for patients with advanced or high-risk breast cancers. Yet most of these patients aren't receiving this potentially lifesaving treatment.
Avastin Will Still be Covered
Even though a U.S. Food and Drug Administration (FDA) panel has voted to no longer approve Avastin ( bevacizumab ) for treating late-stage breast cancers, Medicare has indicated it will continue to pay for the drug.